Targeting TDP-43 in neurodegenerative diseases

By Budini Mauricio   Baralle Francisco E   Buratti Emanuele  

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 6, 2014-06 ,pp. : 617-632

Informa Healthcare

Access to resources Recommend Favorite

Targeting CNS Transporters for Treatment of Neurodegenerative Diseases

By  

Current Pharmaceutical Design, Vol. 20, Iss. 10, 2014-03 ,pp. : 1523-1533

Bentham Science Publishers

Access to resources Recommend Favorite

The emerging utility of animal models of chronic neurodegenerative diseases

By Kahle P.J.   Haass C.  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 1, 2001-02 ,pp. : 125-132

Informa Healthcare

Access to resources Recommend Favorite

Selective targeting of synthetic antioxidants to mitochondria: towards a mitochondrial medicine for neurodegenerative diseases?

By Dessolin J.   Schuler M.   Quinart A.   De Giorgi F.   Ghosez L.   Ichas F.  

European Journal of Pharmacology, Vol. 447, Iss. 2, 2002-07 ,pp. : 155-161

Elsevier

Access to resources Recommend Favorite

Targeting ASK1 in ER stress-related neurodegenerative diseases

By Homma Kengo   Katagiri Kazumi   Nishitoh Hideki   Ichijo Hidenori  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 6, 2009-06 ,pp. : 653-664

Informa Healthcare

Access to resources Recommend Favorite